Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke: A Randomized Controlled Trial

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease

1959 • 14,850 citations

ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale

1975 • 7,367 citations

Measurements of acute cerebral infarction: a clinical examination scale.

1989 • 5,225 citations

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1995 • 3,456 citations

A Multiple Testing Procedure for Clinical Trials

1979 • 3,139 citations

Discrete Sequential Boundaries for Clinical Trials

1983 • 1,584 citations

CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke

1997 • 1,200 citations

The Statistical Analysis of Failure Time Data.

1982 • 927 citations

The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram

1993 • 746 citations

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1995 • 480 citations

Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172)

1993 • 452 citations

Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.

1993 • 214 citations

Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke: A Randomized Controlled Trial

1986 • 207 citations

Accuracy of initial stroke subtype diagnosis in the TOAST study

1995 • 189 citations

Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

1994 • 136 citations

Hemorrhagic transformation in cardioembolic cerebral infarction.

1993 • 110 citations

Early anticoagulation after large cerebral embolic infarction

1995 • 88 citations

Pharmacokinetic Considerations on Orgaran (Org 10172) Therapy

1992 • 72 citations

ORG 10172: a low molecular weight heparinoid anticoagulant with a long half‐life in man.

1987 • 69 citations

Statistical Methods for the Analysis of Biomedical Data.

1989 • 66 citations

Design of the trial of Org 10172 in acute stroke treatment (TOAST)

1997 • 64 citations

A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke

1989 • 40 citations

Measurement in neurologic rehabilitation

1993 • 35 citations

Immediate Anticoagulation With Heparin for First-Ever Ischemic Stroke in the Carotid Artery Territories Observed Within 5 Hours of Onset

1994 • 30 citations